Phase I trial HMR code: 22-014 : Phase I trial HMR code: 22-014 [The full scientific title will be published within 30 months after the end of the trial]
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
WHO International Clinical Trials Registry Platform - (2023) vom: 20. Juni Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Unbestimmt |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 14-06-2023, Last updated: 2023-06-29 |
|---|
| ICTRP ID: |
ISRCTN57043417 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
CTG009339043 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG009339043 | ||
| 003 | DE-627 | ||
| 005 | 20230629100641.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230629s2023 xx |||||o 00| ||und c | ||
| 035 | |a (DE-627)CTG009339043 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)ISRCTN57043417 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)2022-003721-22 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)Nil known | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)IRAS 1006884 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)HMR code: 22-014 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a und | ||
| 245 | 1 | 0 | |a Phase I trial HMR code: 22-014 |b Phase I trial HMR code: 22-014 [The full scientific title will be published within 30 months after the end of the trial] |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 14-06-2023, Last updated: 2023-06-29 | ||
| 650 | 4 | |a Medical Condition: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. Not Applicable | |
| 650 | 4 | |a Study Type: Interventional | |
| 650 | 4 | |a Phase: Phase 1 | |
| 650 | 4 | |a Recruitment Status: Recruiting | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t WHO International Clinical Trials Registry Platform |g (2023) vom: 20. Juni |
| 773 | 1 | 8 | |g year:2023 |g day:20 |g month:06 |
| 856 | 4 | 0 | |u https://www.isrctn.com/ISRCTN57043417 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 20 |c 06 | ||